The global cardiac pacemakers market size was valued at USD 4,446.2 million in 2020 and expected to reach USD 6,182.4 million by 2026, with a CAGR of 5.6% during the forecast period 2021-2026. pacemaker is a small device which is placed in abdomen or chest that helps in controlling abnormal rhythms of heart. Pacemakers used low energy electrical pulses to prompt the heart beat at normal rate. Pacemakers are used in treatment for arrhythmias. Increase in prevalence of heart diseases worldwide boosting Cardiac Pacemakers market globally. According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012 In addition, increase in demand for the invasive techniques in treatment of heart diseases and life style changes bolstering the Cardiac Pacemakers market. Furthermore technological advancements and adaptability are expected to boost the market growth. However, certain risks in Cardiac Pacemakers such as infection at the surgical site, failure to deliver optimum therapy when needed (either extra therapy when it is not needed or no therapy delivered when it is needed), sensitivity to the device material are hampering the Cardiac Pacemakers market. Many countries have endured and continue to incur severe economic and healthcare burdens as a result of the high transmission rate and lack of treatment. Many governments have gone into lockdown, suspending trade with other countries, imposing travel restrictions, and so on, causing large firms’ market capitalizations to plummet around the world.